We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boehringer Ingleheim’s Spiriva Patent Struck Down in India
Boehringer Ingleheim’s Spiriva Patent Struck Down in India
India’s patent office has sided with a challenge from generics maker Cipla and struck down a patent protecting Boehringer Ingleheim’s blockbuster COPD drug Spiriva.